Table III.
Duration of ADT, months | |||
---|---|---|---|
Toxicity | <36, n (%) | ≥36, n (%) | P-value |
Gastrointestinal | |||
Diarrhea | 2 (4) | 19 (16) | 0.02 |
Rectal bleeding | 1 (2) | 0 (0) | 0.31 |
Genitourinary | 8 (15) | 26 (22) | 0.42 |
Cardiovascular | 5 (9) | 0 (0) | <0.01 |
ADT, adrogen deprivation therapy.